Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer

Seasoned Expert Joins to Drive Fractyl’s Pioneering Mission Forward with its Revita® and Rejuva® Programs for Type 2 Diabetes and Obesity Dr. Kieffer’s Stellar Track Record Spans Pioneering Academic Research in Diabetes Mechanisms and Industry Experience with Company Formation and Leadership September 14, 2023 10:08 AM Eastern Daylight Time LEXINGTON, Mass.–(BUSINESS WIRE)–Fractyl Health, a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic … Continue reading Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer

Impact Newswire14/09/202329/05/2024

Europe

Oxular Announces Appointment of Mark Gaffney as Chief Executive Officer

September 11, 2023 08:00 AM Eastern Daylight Time OXFORD, United Kingdom & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oxular Limited, a clinical-stage ophthalmic company developing long-lasting targeted treatments for retinal disorders to improve patients’ vision, today announces that Mark Gaffney has been appointed as chief executive officer (CEO) and member of the Board of Directors. Mr. Gaffney succeeds Thomas Cavanagh, who has transitioned from his role as CEO role … Continue reading Oxular Announces Appointment of Mark Gaffney as Chief Executive Officer

Impact Newswire12/09/202329/05/2024